Part 1: Why AI In Life Sciences Must Be Grounded In Validated Execution
By Nikki Bishop, Emerson
The standard digital playbook says to unify the data, add AI, and let enterprise insight follow. In regulated life sciences production, that sequence runs into a hard constraint: the batch record, executed workflow, material genealogy, and release decision are the system of record, and they carry legal weight. Analytics datasets that drift from validated execution create parallel versions of reality, and batch behavior such as phase-dependent analysis windows defeats tools built for fixed timestamps. This first installment of a two-part series is for manufacturing, IT, and quality leaders deciding where AI sits in the stack. Explore the argument for keeping insight inseparable from execution.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.